FDA Recall of Quality Choice Honey Lemon Cough Drops
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
Xiamen Kang Zhongyuan Biotechnology Co., Ltd. is voluntarily recalling specific lots of Quality Choice Cough Drops due to potential quality issues following an FDA inspection.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on May 3, 2026 and geographically references United States. Its severity classification of "low" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, cpsc, Drugs.
What Happened
The recall was initiated following FDA's recommendation based on certain observations noted during an August 15, 2025, inspection of the manufacturing facility that may bear on product quality.
Which Products Are Affected
The affected product is QC Quality Choice, Menthol-Cough Suppressant Oral Anesthetic, Cough Drops, Honey Lemon Flavor, in 30-count bags. It has NDC: 83698-617-30, UPC: 0635515986732, Lot #: 20240720, and Expiration Date: 07/20/2026. The quantity affected is not specified, and distribution was US Nationwide.
What You Should Do
Consumers who have the affected product should contact the recalling firm, Xiamen Kang Zhongyuan Biotechnology Co., Ltd., at No. 2018, 2 Jietou Road, Xiamen, China, as the initial notification was via letter. Follow the firm's instructions for any returns or refunds.
Why This Matters
This recall addresses potential quality concerns in over-the-counter drugs, underscoring the need for adherence to manufacturing standards to maintain product safety for consumers across the United States.
Source
FDA Recall Number: D-0468-2026
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Nationwide notices with similar length or severity timing 8
Two Areazine-derived peer sets for this FDA recall: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.
Similar body length
Nearest notices by article body length (1,111 characters here).
Similar severity timing
Same severity (low) notices issued closest in time to May 3, 2026.
Frequently Asked Questions
Common questions about this FDA recall.